186 related articles for article (PubMed ID: 36580458)
1. Facilitators and barriers to colorectal cancer screening using the immunochemical faecal occult blood test among an average-risk population in semi-rural Malaysia: A qualitative study.
Ramanathan K; Schliemann D; Binti Ibrahim Tamin NS; Mohan D; Donnelly M; Su TT
PLoS One; 2022; 17(12):e0279489. PubMed ID: 36580458
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a home-based colorectal cancer screening intervention in Malaysia (CRC-SIM).
Schliemann D; Ramanathan K; Ibrahim Tamin NSB; O'Neill C; Cardwell CR; Ismail R; Kassim Z; Kee F; Su TT; Donnelly M
BMC Cancer; 2023 Jan; 23(1):22. PubMed ID: 36609260
[TBL] [Abstract][Full Text] [Related]
3. The Intention and Uptake of Colorectal Cancer Screening after a Brief Health Education Program in a Malaysian Primary Care Setting: A Population-Based Study.
Chan MW; Chean KY; Kader Maideen SF; Kow FP
Asian Pac J Cancer Prev; 2021 Nov; 22(11):3475-3482. PubMed ID: 34837902
[TBL] [Abstract][Full Text] [Related]
4. Barriers and facilitators of implementing a multicomponent intervention to improve faecal immunochemical test (FIT) colorectal cancer screening in primary care clinics, Alberta.
Adhikari K; Mah SS; Patterson M; Teare GF; Manalili K
BMJ Open Qual; 2024 May; 13(2):. PubMed ID: 38802268
[TBL] [Abstract][Full Text] [Related]
5. Colorectal screening using the immunochemical faecal occult blood test kit among the Malaysian cohort participants.
Abdullah N; Abd Jalal N; Ismail N; Kamaruddin MA; Abd Mutalib NS; Alias MR; Mazlan L; Sagap I; Jamal R
Cancer Epidemiol; 2020 Apr; 65():101656. PubMed ID: 31923638
[TBL] [Abstract][Full Text] [Related]
6. Determinants of colorectal carcinoma screening amongst patients attending a public primary care health centre in Johor Bahru.
Rizky NPH; Aznida FAA; Wan Fadhilah WI
Med J Malaysia; 2021 May; 76(3):346-352. PubMed ID: 34031333
[TBL] [Abstract][Full Text] [Related]
7. Barriers and facilitators to participate in the colorectal cancer screening programme in Flanders (Belgium): a focus group study.
Hoeck S; Van Roy K; Willems S
Acta Clin Belg; 2022 Feb; 77(1):37-44. PubMed ID: 32552612
[TBL] [Abstract][Full Text] [Related]
8. Rate and associated factors of refusal to perform immunochemical Faecal Occult Blood Test (iFOBT) among semi-urban communities.
Syed Soffian SS; Safian N; Nawi AM; Ahmad SB; Chan HK; Abu Hassan MR
PLoS One; 2021; 16(10):e0258129. PubMed ID: 34618854
[TBL] [Abstract][Full Text] [Related]
9. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
10. Overview of colorectal cancer screening programme in Malaysia.
Arunah C; Feisul IM; Nor Saleha IT; Muhammad Radzi AH
Med J Malaysia; 2020 May; 75(3):235-239. PubMed ID: 32467538
[TBL] [Abstract][Full Text] [Related]
11. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
12. Reasons for never and intermittent completion of colorectal cancer screening after receiving multiple rounds of mailed fecal tests.
Green BB; BlueSpruce J; Tuzzio L; Vernon SW; Aubree Shay L; Catz SL
BMC Public Health; 2017 May; 17(1):531. PubMed ID: 28558663
[TBL] [Abstract][Full Text] [Related]
13. A 5-year evaluation of using stool-based test for opportunistic colorectal cancer screening in primary health institutions across Malaysia.
Tamin NSI; Razalli KA; Sallahuddin SN; Chan HK; Hassan MRA
Cancer Epidemiol; 2020 Dec; 69():101829. PubMed ID: 32998070
[TBL] [Abstract][Full Text] [Related]
14. Change in public awareness of colorectal cancer symptoms following the Be Cancer Alert Campaign in the multi-ethnic population of Malaysia.
Schliemann D; Paramasivam D; Dahlui M; Cardwell CR; Somasundaram S; Ibrahim Tamin NSB; Donnelly C; Su TT; Donnelly M
BMC Cancer; 2020 Mar; 20(1):252. PubMed ID: 32213173
[TBL] [Abstract][Full Text] [Related]
15. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
[TBL] [Abstract][Full Text] [Related]
16. Knowledge of, attitudes toward, and barriers to participation of colorectal cancer screening tests in the Asia-Pacific region: a multicenter study.
Koo JH; Leong RW; Ching J; Yeoh KG; Wu DC; Murdani A; Cai Q; Chiu HM; Chong VH; Rerknimitr R; Goh KL; Hilmi I; Byeon JS; Niaz SK; Siddique A; Wu KC; Matsuda T; Makharia G; Sollano J; Lee SK; Sung JJ;
Gastrointest Endosc; 2012 Jul; 76(1):126-35. PubMed ID: 22726471
[TBL] [Abstract][Full Text] [Related]
17. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
18. "Fault-line of an earthquake": a qualitative examination of barriers and facilitators to colorectal cancer screening in rural, Eastern North Carolina.
Jilcott Pitts SB; Lea CS; May CL; Stowe C; Hamill DJ; Walker KT; Fitzgerald TL
J Rural Health; 2013; 29(1):78-87. PubMed ID: 23289658
[TBL] [Abstract][Full Text] [Related]
19. The Chinese and Korean American immigrant experience: a mixed-methods examination of facilitators and barriers of colorectal cancer screening.
Jung MY; Holt CL; Ng D; Sim HJ; Lu X; Le D; Juon HS; Li J; Lee S
Ethn Health; 2018 Nov; 23(8):847-866. PubMed ID: 28277021
[TBL] [Abstract][Full Text] [Related]
20. Exploration of Malaysian Stakeholders View on Barriers to and Facilitators of Colorectal Cancer Screening Among Older Population.
Doraimuthu S; Dahlui M; Hoe VCW; Su TT
Asia Pac J Public Health; 2023 Jan; 35(1):27-33. PubMed ID: 36588191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
